In Bacterial infections Ceftas CL 200 mg Tablet is a medicine that helps to kill the bacteria that cause infections. This combination medicine can be used to treat many different bacterial infections. It causes loss of the useful bacteria that are present naturally in our body. It contains probiotics that help restore the useful bacteria, improve digestion and enhance overall health. Ceftas CL 200 mg Tablet usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
It is not known whether it is safe to consume alcohol with Ceftas CL 200 mg Tablet. Please consult your doctor.
Information regarding the use of Ceftas CL 200 mg Tablet during pregnancy is not available. Please consult your doctor.
Ceftas CL 200 mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Ceftas CL 200 mg Tablet does not usually affect your ability to drive.
Ceftas CL 200 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Ceftas CL 200 mg Tablet may be needed. Please consult your doctor. Regular monitoring of kidney function tests is advised while taking this medicine.
Ceftas CL 200 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Ceftas CL 200 mg Tablet may be needed. Please consult your doctor. Regular monitoring of liver function tests is advised while taking this medicine.
If you miss a dose of Ceftas CL 200 mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Doux Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vardhman Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sakshit Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: FDC Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ridhima Biocare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zuventus Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Elder Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Medley Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Euro Organics || ₹14.5/tablet (25% cheaper)